BSEBoard Meeting6d ago · 1 Aug 2026, 03:51 pm

Emmessar Biotech & Nutrition Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve please refer attachment

Emmessar Biotech & Nutrition Ltd · 524768

✦ AI SummaryResults

Emmessar Biotech & Nutrition Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 07/08/2026 to consider and approve unaudited Financial Results for the quarter ended June 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Emmessar Biotech & Nutrition Ltd - 524768 - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30, 2026

Attachments (1)

📄

e2d23b80-752e-41af-b6ee-a5437688e77f.pdf

pdf

Download →
View document text
EMMESSAR BIOTECH & NUTRITION LIMITED 29, Kamer Building, 4th floor, 38, Cawasji Patel Street, Fort, Mumbai – 400 001 Tel: 022-35661373 / 35664530 Email: enquiries@ebnl.org Website: www.ebnl.org Investors Grievance Email: investors@ebnl.org CIN No. L24110MH1992PLC065942 Date: August 01, 2026 The Manager Listing Department, Bombay Stock Exchange Limited, P. J. Tower, Dalal Street, Mumbai – 400 001 Ref: -Security Code No. 524768 Sub: Intimation of Board Meeting –Audited Financial Results Dear Sir/Madam, This is to inform you, pursuant to Regulation 29 (1) (a) of Securities and Exchange Board of India (Listing Obligations and Disclosure requirements) Regulations, 2015, that a meeting of the Board of Directors of the Company will be held on Friday the August 07, 2026, at Mumbai, inter alia: To consider and approve unaudited Financial Results of the Company for the quarter ended June 30, 2026. Further, pursuant SEBI (Prohibition of Insider Trading), Regulations, 2015, as amended from time to time the Trading Window, as informed to the exchange vide letter dated 26.06.2026 in respect of trading in equity shares of the Company will remain closed upto August 09, 2026. Kindly take the above on your record and oblige. Thanking you, Yours faithfully, For EMMESSAR BIOTECH & NUTRITION LIMITED Priyanka Sharma Company Secretary Regd. Office & Factory: Plot No. T-3/2, MIDC Area, Taloja – 410208. Dist. Raigad. Maharashtra. Email: enquiries@ebnl.org Website: www.ebnl.org